Thermo Fisher's $860M Volume Ranks 115th as Stock Gains 1.32% on Strategic Moves

. 16, 2025, , . The stock's performance followed a strategic review of its capital allocation framework, . Analysts noted the move reinforced confidence in the company's ability to generate consistent cash flows amid evolving regulatory landscapes in life sciences. The authorization, combined with a revised dividend policy, positioned TMO to potentially outperform peers in sectors with high reinvestment needs.

Market participants observed that the stock's recent momentum aligned with broader sector rotation toward defensive healthcare names. increased exposure to TMO through options activity, . This trend suggested positioning for near-term upside potential, particularly as the company approaches its quarterly earnings release in mid-October. , , indicating limited bearish conviction.

To build and back-test the “buy the top-500-by-volume every day and hold for one day” strategy we need to clarify two practical details: 1. Universe definition • Should the ranking be done across all U.S. listed stocks, or inside a specific index/universe (e.g., S&P 500, Russell 3000, NASDAQ, etc.)? 2. Weighting scheme • Do we treat the 500 names equally-weighted each day, or use another weighting (e.g., volume-weighted, market-cap-weighted)? Once these are set I can fetch the required daily volume data, generate the daily “top-500” lists, create the one-day-holding signals, and run the back-test from 2022-01-01 to the present. Let me know your preference and I’ll proceed immediately.